Mohs micrographic surgery for penile carcinoma with urethral invasion: A multidisciplinary approach - 14/10/20
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Funding sources: Supported in part through the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation, review, or approval of the manuscript; or in the decision to submit the manuscript for publication. |
|
Disclosure: Dr Rossi has received research grants from Leo iLab, American Society for Laser Medicine and Surgery, Regen, and the Skin Cancer Foundation; served as a consultant for Merz, Biofrontera, DynaMed, Canfield Scientific, Evolus, QuantiaMD, Lam Therapeutics, Cutera, and Skinfix; sat on an advisory board for Allergan Inc and Regeneron Inc; received travel grants from MAVIG and L'Oréal; and received an equipment loan from PerfAction. Dr Erlendsson has received a research grant from Leo iLab and an equipment loan from PerfAction. Authors Wilson, Bellia, and Phillips and Dr Leddy have no conflicts of interest to declare. |
|
IRB approval status: A retrospective review was conducted under institutional review board approval from the Memorial Sloan Kettering Cancer Center (IRB 16-458). |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?